Warren A Young
Examiner (ID: 12325)
Most Active Art Unit | 1711 |
Art Unit(s) | 1711 |
Total Applications | 3 |
Issued Applications | 0 |
Pending Applications | 0 |
Abandoned Applications | 3 |
Applications
Application number | Title of the application | Filing Date | Status |
---|---|---|---|
Array
(
[id] => 15457335
[patent_doc_number] => 20200041492
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-02-06
[patent_title] => BIOMARKERS FOR CELLULAR SENESCENCE
[patent_app_type] => utility
[patent_app_number] => 16/492410
[patent_app_country] => US
[patent_app_date] => 2018-03-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13668
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16492410
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/492410 | BIOMARKERS FOR CELLULAR SENESCENCE | Mar 8, 2018 | Pending |
Array
(
[id] => 14808831
[patent_doc_number] => 20190271025
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-09-05
[patent_title] => METHOD TO DETECT PRE-SYMPTOM EARLY CANCER WITH ENHANCED ACCURACY
[patent_app_type] => utility
[patent_app_number] => 15/912153
[patent_app_country] => US
[patent_app_date] => 2018-03-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 40045
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 111
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15912153
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/912153 | METHOD TO DETECT PRE-SYMPTOM EARLY CANCER WITH ENHANCED ACCURACY | Mar 4, 2018 | Abandoned |
Array
(
[id] => 13444993
[patent_doc_number] => 20180274039
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-09-27
[patent_title] => METHYLATION MARKERS FOR DIAGNOSING HEPATOCELLULAR CARCINOMA AND LUNG CANCER
[patent_app_type] => utility
[patent_app_number] => 15/910857
[patent_app_country] => US
[patent_app_date] => 2018-03-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 44622
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -27
[patent_words_short_claim] => 121
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15910857
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/910857 | Methylation markers for diagnosing hepatocellular carcinoma and lung cancer | Mar 1, 2018 | Issued |
Array
(
[id] => 18825463
[patent_doc_number] => 11840734
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-12-12
[patent_title] => Method for analyzing aurka expression
[patent_app_type] => utility
[patent_app_number] => 16/494949
[patent_app_country] => US
[patent_app_date] => 2018-03-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 5
[patent_no_of_words] => 29767
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 264
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16494949
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/494949 | Method for analyzing aurka expression | Feb 28, 2018 | Issued |
Array
(
[id] => 17075154
[patent_doc_number] => 11111540
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-09-07
[patent_title] => Assessment of risk of aneuploidy
[patent_app_type] => utility
[patent_app_number] => 15/905665
[patent_app_country] => US
[patent_app_date] => 2018-02-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 13332
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 223
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15905665
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/905665 | Assessment of risk of aneuploidy | Feb 25, 2018 | Issued |
Array
(
[id] => 16832383
[patent_doc_number] => 11008624
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-05-18
[patent_title] => Methods for predicting prostate cancer relapse
[patent_app_type] => utility
[patent_app_number] => 15/890789
[patent_app_country] => US
[patent_app_date] => 2018-02-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 15
[patent_no_of_words] => 20689
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 111
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15890789
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/890789 | Methods for predicting prostate cancer relapse | Feb 6, 2018 | Issued |
Array
(
[id] => 16073195
[patent_doc_number] => 20200190584
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-06-18
[patent_title] => HSMI DISEASE RESISTANCE IN SALMONIDS
[patent_app_type] => utility
[patent_app_number] => 16/481807
[patent_app_country] => US
[patent_app_date] => 2018-01-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8094
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -11
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16481807
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/481807 | HSMI disease resistance in salmonids | Jan 29, 2018 | Issued |
Array
(
[id] => 12838732
[patent_doc_number] => 20180171417
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-06-21
[patent_title] => DETECTION OF SINGLE NUCLEOTIDE POLYMORPHISMS IN HUMAN KRAS
[patent_app_type] => utility
[patent_app_number] => 15/878851
[patent_app_country] => US
[patent_app_date] => 2018-01-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 25532
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -8
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15878851
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/878851 | DETECTION OF SINGLE NUCLEOTIDE POLYMORPHISMS IN HUMAN KRAS | Jan 23, 2018 | Abandoned |
Array
(
[id] => 17497832
[patent_doc_number] => 11286525
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-03-29
[patent_title] => Gene expression signatures useful to predict or diagnose sepsis and methods of using the same
[patent_app_type] => utility
[patent_app_number] => 16/478202
[patent_app_country] => US
[patent_app_date] => 2018-01-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 10
[patent_no_of_words] => 19927
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 167
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16478202
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/478202 | Gene expression signatures useful to predict or diagnose sepsis and methods of using the same | Jan 15, 2018 | Issued |
Array
(
[id] => 13462537
[patent_doc_number] => 20180282811
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-10-04
[patent_title] => METHODS FOR DIAGNOSING, PROGNOSING, OR THERANOSING A CONDITION USING RARE CELLS
[patent_app_type] => utility
[patent_app_number] => 15/870945
[patent_app_country] => US
[patent_app_date] => 2018-01-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11637
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -10
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15870945
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/870945 | METHODS FOR DIAGNOSING, PROGNOSING, OR THERANOSING A CONDITION USING RARE CELLS | Jan 12, 2018 | Abandoned |
Array
(
[id] => 12770887
[patent_doc_number] => 20180148797
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-05-31
[patent_title] => POLYNUCLEOTIDE PROBE, METHOD FOR DETECTING A TARGET NUCLEIC ACID BY USING THE SAME AND KIT COMPRISING THE SAME
[patent_app_type] => utility
[patent_app_number] => 15/870336
[patent_app_country] => US
[patent_app_date] => 2018-01-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7037
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15870336
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/870336 | Polynucleotide probe, method for detecting a target nucleic acid by using the same and kit comprising the same | Jan 11, 2018 | Issued |
Array
(
[id] => 13300935
[patent_doc_number] => 20180202004
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-07-19
[patent_title] => METHODS FOR PREDICTING DRUG RESPONSIVENESS IN CANCER PATIENTS
[patent_app_type] => utility
[patent_app_number] => 15/858703
[patent_app_country] => US
[patent_app_date] => 2017-12-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 75352
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -20
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15858703
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/858703 | Methods for predicting drug responsiveness in cancer patients | Dec 28, 2017 | Issued |
Array
(
[id] => 18518728
[patent_doc_number] => 11708611
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-07-25
[patent_title] => Method for diagnosing prostatic disease via bacterial metagenomic analysis
[patent_app_type] => utility
[patent_app_number] => 16/474543
[patent_app_country] => US
[patent_app_date] => 2017-12-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 17
[patent_figures_cnt] => 17
[patent_no_of_words] => 9320
[patent_no_of_claims] => 1
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 701
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16474543
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/474543 | Method for diagnosing prostatic disease via bacterial metagenomic analysis | Dec 26, 2017 | Issued |
Array
(
[id] => 16169751
[patent_doc_number] => 10711302
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-07-14
[patent_title] => Predicting resistance to disease
[patent_app_type] => utility
[patent_app_number] => 15/848434
[patent_app_country] => US
[patent_app_date] => 2017-12-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 6720
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 61
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15848434
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/848434 | Predicting resistance to disease | Dec 19, 2017 | Issued |
Array
(
[id] => 12707962
[patent_doc_number] => 20180127820
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-05-10
[patent_title] => PREDICTING RESISTANCE TO DISEASE
[patent_app_type] => utility
[patent_app_number] => 15/848386
[patent_app_country] => US
[patent_app_date] => 2017-12-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6749
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -5
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15848386
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/848386 | Predicting resistance to disease | Dec 19, 2017 | Issued |
Array
(
[id] => 15148453
[patent_doc_number] => 20190352704
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-11-21
[patent_title] => BENIGN THYROID NODULE-SPECIFIC GENE
[patent_app_type] => utility
[patent_app_number] => 16/467573
[patent_app_country] => US
[patent_app_date] => 2017-12-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4801
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -7
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16467573
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/467573 | BENIGN THYROID NODULE-SPECIFIC GENE | Dec 6, 2017 | Abandoned |
Array
(
[id] => 12746233
[patent_doc_number] => 20180140578
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-05-24
[patent_title] => METHODS AND COMPOSITIONS FOR THE DIAGNOSIS AND SELECTIVE TREATMENT OF CANCER
[patent_app_type] => utility
[patent_app_number] => 15/821111
[patent_app_country] => US
[patent_app_date] => 2017-11-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 32325
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 59
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15821111
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/821111 | METHODS AND COMPOSITIONS FOR THE DIAGNOSIS AND SELECTIVE TREATMENT OF CANCER | Nov 21, 2017 | Abandoned |
Array
(
[id] => 12751399
[patent_doc_number] => 20180142300
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-05-24
[patent_title] => UNIVERSAL HAPLOTYPE-BASED NONINVASIVE PRENATAL TESTING FOR SINGLE GENE DISEASES
[patent_app_type] => utility
[patent_app_number] => 15/818138
[patent_app_country] => US
[patent_app_date] => 2017-11-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 29030
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -36
[patent_words_short_claim] => 388
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15818138
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/818138 | UNIVERSAL HAPLOTYPE-BASED NONINVASIVE PRENATAL TESTING FOR SINGLE GENE DISEASES | Nov 19, 2017 | Abandoned |
Array
(
[id] => 13358003
[patent_doc_number] => 20180230541
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-08-16
[patent_title] => METHOD FOR PREDICTING THE ONSET OF EXTRAPYRAMIDAL SYMPTOMS (EPS) INDUCED BY AN ANTIPSYCHOTIC-BASED TREATMENT
[patent_app_type] => utility
[patent_app_number] => 15/815967
[patent_app_country] => US
[patent_app_date] => 2017-11-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8953
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -8
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15815967
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/815967 | Method for predicting the onset of extrapyramidal symptoms (EPS) induced by an antipsychotic-based treatment | Nov 16, 2017 | Issued |
Array
(
[id] => 14930657
[patent_doc_number] => 20190300966
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-10-03
[patent_title] => Methods for Diagnosing Cancer
[patent_app_type] => utility
[patent_app_number] => 16/335605
[patent_app_country] => US
[patent_app_date] => 2017-11-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19328
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16335605
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/335605 | Methods for diagnosing cancer | Nov 7, 2017 | Issued |